Angel Robotics
South Korean wearable robotics company founded in 2017, known for rehabilitation exoskeletons such as AngelX M20 and the Angel Suit.
Last updated September 26, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Angel Robotics is a South Korean wearable robotics company founded in 2017. It develops wearable robots that interact naturally with the human body, focusing on three core technologies: understanding human movement intention, designing and controlling actuators with precise force control, and generating human-adaptive gait trajectories and assistance forces. The company also works on internalizing key components. Its technology has been validated through two consecutive gold medals (2020 and 2024) at the Cybathlon, an international competition for people with physical disabilities using bionic assistive devices. Its flagship products include AngelX M20, a rehabilitation wearable robot for patients with incomplete lower-limb paralysis due to stroke or Parkinson's disease; Angel Suit, a muscle-assist wearable robot for returning to daily life; and Angel X, a product for various industrial safety environments. AngelX M20 became the first wearable robot to receive Class 3 medical device certification in December 2022, enabling medical reimbursement (MM304), and is used in various medical institutions including tertiary hospitals. In March 2024, Angel Robotics listed on the KOSDAQ market. The company is pursuing global certifications for overseas expansion and is promoting a 'connected healthcare' business covering the full rehabilitation cycle, from hospital treatment to continuous home healthcare.
History
Angel Robotics was founded in February 2017 as SG Robotics Co., Ltd. In May 2017, it received seed investment from LG Electronics. In August 2018, the company changed its name to Angel Robotics. In December 2019, it was awarded 'Korea Robot Company of the Year' in the personal service robot category. In January 2020, it raised 9.7 billion won in Series A funding. In November 2020, it won gold and bronze medals in the powered exoskeleton category at the Cybathlon. In December 2020, it again won 'Korea Robot Company of the Year'. In July 2021, it raised 18 billion won in Series B funding. In December 2021, it won the same award again. In May 2022, it signed a strategic agreement (MOA) with UiTM (Universiti Teknologi MARA) in Malaysia and supplied AngelX M20 to Daehan Rehabilitation Hospital. In August 2022, it launched 'ANGEL X', a wearable suit for muscle assistance. In October 2022, 'ANGEL X' was selected for the Ministry of National Defense's second-half 2022 excellent commercial product pilot use program. In December 2022, 'ANGEL X' was registered with the US FDA, and AngelX M20 received Class 3 medical device approval. In December 2022, it won 'Korea Robot Company of the Year' again. In February 2023, it signed a gait training robot supply contract and business agreement with Yonsei University Rehabilitation Hospital. In August 2023, it raised 10 billion won in Series C funding. In September 2023, it signed an MOU with LIG Nex1 for commercialization of wearable robots. In December 2023, it won 'Korea Robot Company of the Year' again. In March 2024, it listed on the KOSDAQ market. In April 2024, it opened a production facility at Planet Hanam. In July 2024, it opened a advanced research institute at Planet Daejeon. In July 2024, a paper on 'Ground gait training using wearable robots for children with cerebral palsy' was published in JAMA Network Open. In July 2024, Cho Nam-min was appointed as new CEO. In October 2024, it won a gold medal in the powered exoskeleton category at the 3rd Cybathlon (second consecutive). In December 2024, it won 'Korea Robot Company of the Year' again.
- 2024
Listed on KOSDAQ market
- 2024
Opened production facility at Planet Hanam
- 2024
Opened advanced research institute at Planet Daejeon
- 2024
Paper on wearable robot gait training for children with cerebral palsy published in JAMA Network Open
- 2024
Cho Nam-min appointed as new CEO
- 2024
Won gold medal at 3rd Cybathlon (powered exoskeleton category, second consecutive)
- 2023
Signed gait training robot supply contract and business agreement with Yonsei University Rehabilitation Hospital
- 2023
Raised 10 billion won in Series C funding
- 2023
Signed MOU with LIG Nex1 for wearable robot commercialization
- 2022
Signed MOA with UiTM Malaysia and supplied AngelX M20 to Daehan Rehabilitation Hospital
Products and positioning
Developer of wearable robots for rehabilitation, daily assistance, and industrial safety, with a focus on human-robot interaction and medical-grade certification.
AngelX M20
Wearable exoskeleton gait assist robot for rehabilitation of patients with incomplete lower-limb paralysis; first wearable robot to receive Class 3 medical device certification in December 2022; used in hospitals.
Angel Suit
Wearable robot for patients with mild gait disorders returning to daily life; AI-based force control; includes Angel Suit H10 (hip assist) and future Angel Suit K10 (knee assist).
Angel X
Unpowered wearable assistive suit for preventing musculoskeletal injuries in industrial workers; no battery or actuator; registered with US FDA in December 2022.
Angel Kit
Wearable robot component brand including inertial measurement module (IM10), actuator module (AM10), motor driver (MD10), and smart actuator module (SAM10).
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/angel-robotics · Editorial policy · How profiles are compiled